Lawyers and Settlements
What are you looking for?
Home Page >> Zyprexa Diabetes >> Articles

Zyprexa Articles

Zyprexa on Trial in Alaska: Lilly Accused of Putting Profit Before Patients

Zyprexa on Trial in Alaska: Lilly Accused of Putting Profit Before Patients March 9, 2008. By Gordon Gibb.
Anchorage, AK: Spectators in a courtroom in Anchorage are getting an earful about how Zyprexa maker Eli Lilly waited, according to a witness, almost nine years to add warnings to Zyprexa with regard to a risk for diabetes, elevated blood sugar levels and weight gain.
Read [ Zyprexa on Trial in Alaska: Lilly Accused of Putting Profit Before Patients ]

Swedish Professor Slams Zyprexa, Pulls no Punches

Swedish Professor Slams Zyprexa, Pulls no Punches November 22, 2007. By Gordon Gibb.
Hagersten, Sweden: Zyprexa is the sixth largest seller in Sweden, in all categories, and Rolf Adolfsson isn't happy about that. Unhappy, because the endocrine effects of Zyprexa are extremely dangerous, so says the noted Swedish professor of Psychiatry.
Read [ Swedish Professor Slams Zyprexa, Pulls no Punches ]

Zyprexa Side Effects are Deadly

November 21, 2007. By Heidi Turner.
St. Petersburg, FL: There appears to be no group that is safe from the deadly side effects of Zyprexa. Seniors with dementia who are given the drug are at an increased risk of death, adults and children have a risk of suicidal tendencies and those who survive that may suffer from serious weight gain and diabetes. With all these potentially dangerous side effects associated with Zyprexa, can it still be said that the benefits of the drug outweigh the risks?
Read [ Zyprexa Side Effects are Deadly ]

Zyprexa: The Manipulation, and the Money

November 16, 2007. By Gordon Gibb.
Indianapolis, IN: As concern escalates over atypical antipsychotic drug Zyprexa, its complex assortment of serious side effects and the drug's association with patients who shouldn't be on it in the first place, a small window of enlightenment appears in the unlikeliest of places--You Tube.
Read [ Zyprexa: The Manipulation, and the Money ]

Lilly Faces Mounting Legal Battles Over Zyprexa - Part II

November 10, 2007. By Evelyn Pringle.
Washington, DC: Several Zyprexa-related class actions have been filed against Eli Lilly on behalf of the company's shareholders charging Lilly, and certain of its officers and directors, with violations of the Securities Exchange Act.
Read [ Lilly Faces Mounting Legal Battles Over Zyprexa - Part II ]

Lilly Faces Mounting Legal Battles Over Zyprexa - Part I

Lilly Faces Mounting Legal Battles Over Zyprexa - Part I November 8, 2007. By Evelyn Pringle.
Washington, DC: Since August 2006, as part of an on-going, multistate investigative effort by approximately 30 states, Eli Lilly has received civil investigative demands or subpoenas seeking a broad range of documents relating to the company's marketing and promotion of the antipsychotic drug
Read [ Lilly Faces Mounting Legal Battles Over Zyprexa - Part I ]

Zyprexa and the Unanswered Question: Is it Safe?

November 5, 2007. By Gordon Gibb.
Indianapolis, IN: If the
Read [ Zyprexa and the Unanswered Question: Is it Safe? ]

Zyprexa: In the Drug Business, the Gain is Worth the Risk

Zyprexa: In the Drug Business, the Gain is Worth the Risk October 26, 2007. By Gordon Gibb.
Indianapolis, IN: Eli Lilly knew that there were problems with Zyprexa from the very beginning. But even amidst a flurry of personal injury lawsuits, and the revelation of risk factors for diabetes and other metabolic complications, Zyprexa has grown to become a huge profit center for its manufacturer.
Read [ Zyprexa: In the Drug Business, the Gain is Worth the Risk ]

Zyprexa and the Adolescent: Eli Lilly Seeks Approval to Market to Teens

Zyprexa and the Adolescent: Eli Lilly Seeks Approval to Market to Teens October 24, 2007. By Gordon Gibb.
Indianapolis, IN: The drug Zyprexa, already known to cause weight gain and other metabolic complications that can be accentuated among adolescents, may soon be marketed to teens if Eli Lilly has its way.
Read [ Zyprexa and the Adolescent: Eli Lilly Seeks Approval to Market to Teens ]

Zyprexa linked to Diabetes: Two Accounts

Zyprexa linked to Diabetes: Two Accounts August 23, 2007. By Jane Mundy.
Boise, ID: In 2000, James Jupin's psychiatrist prescribed Zyprexa to control his paranoid schizophrenia. About one year later, 37-year-old Jupin began to show signs of diabetes and hyperglycemia. "He was pretty active and had an average diet," says Gloria, his wife. "And there was no diabetes on either side of his family so this was a real shock."
Read [ Zyprexa linked to Diabetes: Two Accounts ]


Legal Services:

Facebook





Better Business Bureau

CAALA

Best of the Web Approved

Public Justice
 
FAQ | TOS | Privacy | Disclaimer | About Us | Contact Us | Press | Advertise | Member Login | Site Map

This work is licensed under a Creative Commons Attribution-NoDerivs 3.0 Unported License © 2001-2012 Online Legal Media. All rights reserved.